Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MYLAN PHARMACEUTICALS INC. v. SEBELIUS et al
Case Number:
1:12-cv-00524
Court:
Nature of Suit:
Judge:
Firms
Companies
Government Agencies
Sectors & Industries:
-
June 08, 2012
Mylan, Teva Settle Over Generic Provigil Market Rights
Mylan Inc. has settled its dispute with Teva Pharmaceuticals USA Inc. concerning its suit against the U.S. Food and Drug Administration over allegations that Teva and subsidiary Cephalon Inc. worked to stymie generic competition of the sleep disorder drug Provigil, Mylan said Friday.
-
April 24, 2012
Mylan Loses Bid To Block Teva's Provigil Market Rights
A judge on Monday rejected Mylan Pharmaceuticals Inc.'s argument that Teva Pharmaceuticals USA Inc. and its affiliate Cephalon Inc. had worked together to stymie generic competition of sleep disorder drug Provigil and shot down Mylan's bid to block additional market exclusivity granted to Teva by federal regulators.
-
April 18, 2012
Mylan Fights FDA On Teva's Provigil Market Rights
Mylan Inc. asked a federal judge Wednesday to block the U.S. Food and Drug Administration's decision giving Teva Pharmaceuticals USA Inc. 180-day exclusivity to market a generic version of Provigil, arguing Teva and its affiliate Cephalon Inc. had worked together to stymie generic competition of the Cephalon sleep disorder drug.